Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mitochondrial dysfunction is a key factor in Parkinson's disease (PD) pathogenesis.
• Abnormal mitochondrial dynamics and quality control are implicated in PD.
• VPS35 mutations are linked to autosomal-dominant PD, but the underlying mechanisms are unclear.

Purpose of the Study:

• To investigate how VPS35 mutations lead to neurodegeneration in Parkinson's disease.
• To elucidate the role of VPS35 in mitochondrial dynamics and neuronal health.

Main Methods:

• Studied the effects of PD-associated VPS35 mutations in cultured neurons, mouse models, and human fibroblasts.
• Assessed mitochondrial fragmentation, cell death, and interaction with dynamin-like protein 1 (DLP1).
• Investigated the impact of inhibiting mitochondrial fission and the role of oxidative stress.

Main Results:

• VPS35 mutations induced mitochondrial fragmentation and cell death in vitro and in vivo.
• Inhibition of mitochondrial fission prevented VPS35-induced mitochondrial deficits and neuronal dysfunction.
• VPS35 mutants showed increased interaction with DLP1, leading to enhanced turnover of mitochondrial complexes for lysosomal degradation.
• Oxidative stress exacerbated the VPS35-DLP1 interaction, which was also elevated in sporadic PD brains.

Conclusions:

• PD-associated VPS35 mutations disrupt mitochondrial fission regulation.
• Dysregulation of mitochondrial dynamics via VPS35 is a novel mechanism contributing to familial and potentially sporadic Parkinson's disease.
• Targeting mitochondrial fission presents a potential therapeutic strategy for PD.